|About the Speakers
Leanne Kemp, Queensland Chief Entrepreneur
Founder & CEO, Everledger
Leanne Kemp is Founder and CEO of Everledger and Queensland Chief Entrepreneur. She is a prominent figure in the technology sector and recognised internationally as an innovator and leader. Her company Everledger uses Blockchain technology to track high-value assets such as diamonds, art and wine with the aim of increasing transparency and trust with technology.
In 2018, her entrepreneurial success saw her appointed as the Queensland Chief Entrepreneur in Australia, to develop the state’s startup ecosystem, attract investment and support job creation. She is the first woman entrepreneur to hold this position. In 2019 her tenure as Chief Entrepreneur was extended for another year, the first time the role has been extended since its creation.
Leanne works on a global scale to encourage entrepreneurship and innovation and is an advocate of sustainability in business. Leanne’s roles include:
Leanne is a two times Patent Inventor as well as holding the following prominent awards include:
- CEO and Founder, Everledger
- Queensland Chief Entrepreneur
- Co-Chair, Global Future Council on the Future of Manufacturing, World Economic Forum
- Member, Global Future Council on Blockchain, Circular Economy and Global Battery Alliance with the World Economic Forum
- Board of Stewards for Accelerating Sustainable Production, World Economic Forum
- Co-Chair, Sustainable Trade Action Group, World Trade Board
- Advisor, IBM Blockchain Platform Board of Advisors
- Adjunct Professor at the Institute for Future Environment, Queensland University of Technology
- Advancing Identification Matter (AIM) Global Allan Gilligan Award 2019
- Advance Technology Innovation Award 2018
- Innovator of the Year 2018 (Women in IT Awards, London)
- Innovator of the Year 2016 (Women in IT Awards, London)
- Top 26 Coolest Women in UK Tech, 2016 (Business Insider)
- Top 30 Female Innovators (Brummell Magazine)
Professor Trent Munro, Director – National Biologics Facility
Program Director – Rapid Response Vaccine Pipeline
Australian Institute for Bioengineering and Nanotechnology - The University of Queensland
Professor Trent Munro is a Biotechnology professional with extensive experience in the development of a wide array of biological and synthetic therapeutic modalities. He is currently a Senior Group Leader at the Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland where he is Director of the National Biologics Facility and Program Director for the CEPI funded Vaccine Rapid Response pipeline. Prior to this, he was Executive Director of Process Development at Amgen Inc., based in California. In this role, Trent was involved in the translation of molecules from research, through clinical trials and multiple commercial product launches. Prof. Munro has a PhD in Protein Biochemistry from UQ and completed postdoctoral studies in cell biology and developmental genetics at the Department of Cell Biology, Harvard Medical School and the Wellcome Trust and Cancer Research UK Gurdon Institute, University of Cambridge.
Michael Kemp, Executive General Manager – New Generation Building Materials (NGBM), Wagners
Michael was appointed General Manager of Wagner Composite Fibre Technologies in March 2017 and has been employed by Wagners for over 17 years.
Michael has over 20 years’ experience in the construction materials industry and managed the design and installation of the first composite fibre road bridge in Australia (Grafton NSW) as well as the first in Queensland (Blackbutt – D’Aguilar Highway).
Michael holds a Bachelor of Engineering degree from the University of Adelaide.
Toni Bache, Vice President – Business Strategy, International, Trauma & Extremities, Stryker
Toni is an accomplished global executive with nearly 20 years’ experience partnering with other senior executives to help them transform, optimise and grow their business.
Toni truly excels at leading strategy, people and culture. She is currently the Vice President of Business Strategy, International for the Trauma & Extremities division of Stryker, an $11B+, Fortune 300, leading medical technology company.
With experience in healthcare, technology, hospitality, government, and fast moving consumer goods, Toni has worked both virtually and on-the-ground with executives and leadership teams in over 30 countries, and has lived in Australia, United Kingdom and The Netherlands as well as working expansively across Europe, the United States, Asia Pacific and South Africa.